Lancet J - Search Results

1

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.

Sallman DA, Komrokji R, Vaupel C, Cluzeau T, Geyer SM, McGraw KL, Al Ali NH, Lancet J, McGinniss MJ, Nahas S, Smith AE, Kulasekararaj A, Mufti G, List A, Hall J, Padron E. Sallman DA, et al. Among authors: lancet j. Leukemia. 2016 Mar;30(3):666-73. doi: 10.1038/leu.2015.304. Epub 2015 Oct 30. Leukemia. 2016. PMID: 26514544 Free PMC article.

2

Interrogation of molecular profiles can help in differentiating between MDS and AML with MDS-related changes.

Badar T, Szabo A, Sallman D, Komrojki R, Lancet J, Padron E, Song J, Hussaini MO. Badar T, et al. Among authors: lancet j. Leuk Lymphoma. 2020 Jun;61(6):1418-1427. doi: 10.1080/10428194.2020.1719089. Epub 2020 Feb 4. Leuk Lymphoma. 2020. PMID: 32013644

3

Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium.

Zeidan AM, Al Ali N, Barnard J, Padron E, Lancet JE, Sekeres MA, Steensma DP, DeZern A, Roboz G, Jabbour E, Garcia-Manero G, List A, Komrokji R. Zeidan AM, et al. Among authors: lancet je. Leukemia. 2017 Jun;31(6):1391-1397. doi: 10.1038/leu.2017.33. Epub 2017 Jan 23. Leukemia. 2017. PMID: 28111463

4

Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858.

Eksioglu EA, Chen X, Heider KH, Rueter B, McGraw KL, Basiorka AA, Wei M, Burnette A, Cheng P, Lancet J, Komrokji R, Djeu J, List A, Wei S. Eksioglu EA, et al. Among authors: lancet j. Leukemia. 2017 Oct;31(10):2172-2180. doi: 10.1038/leu.2017.21. Epub 2017 Jan 18. Leukemia. 2017. PMID: 28096534 Free PMC article.

5

A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia.

Lancet JE, Ravandi F, Ricklis RM, Cripe LD, Kantarjian HM, Giles FJ, List AF, Chen T, Allen RS, Fox JA, Michelson GC, Karp JE. Lancet JE, et al. Leukemia. 2011 Dec;25(12):1808-14. doi: 10.1038/leu.2011.157. Epub 2011 Jul 15. Leukemia. 2011. PMID: 21760592 Free PMC article. Clinical Trial.

6

Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion.

Wei S, Chen X, McGraw K, Zhang L, Komrokji R, Clark J, Caceres G, Billingsley D, Sokol L, Lancet J, Fortenbery N, Zhou J, Eksioglu EA, Sallman D, Wang H, Epling-Burnette PK, Djeu J, Sekeres M, Maciejewski JP, List A. Wei S, et al. Among authors: lancet j. Oncogene. 2013 Feb 28;32(9):1110-20. doi: 10.1038/onc.2012.139. Epub 2012 Apr 23. Oncogene. 2013. PMID: 22525275 Free PMC article.

7

Treatment of deletion 5q acute myeloid leukemia with lenalidomide.

Lancet JE, List AF, Moscinski LC. Lancet JE, et al. Leukemia. 2007 Mar;21(3):586-8. doi: 10.1038/sj.leu.2404526. Epub 2007 Jan 18. Leukemia. 2007. PMID: 17230228 No abstract available.

8

5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation.

Field T, Perkins J, Huang Y, Kharfan-Dabaja MA, Alsina M, Ayala E, Fernandez HF, Janssen W, Lancet J, Perez L, Sullivan D, List A, Anasetti C. Field T, et al. Among authors: lancet j. Bone Marrow Transplant. 2010 Feb;45(2):255-60. doi: 10.1038/bmt.2009.134. Epub 2009 Jun 22. Bone Marrow Transplant. 2010. PMID: 19543327

9

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia.

Lancet JE, Gojo I, Burton M, Quinn M, Tighe SM, Kersey K, Zhong Z, Albitar MX, Bhalla K, Hannah AL, Baer MR. Lancet JE, et al. Leukemia. 2010 Apr;24(4):699-705. doi: 10.1038/leu.2009.292. Epub 2010 Jan 28. Leukemia. 2010. PMID: 20111068 Clinical Trial.

10

Effects of the farnesyl transferase inhibitor R115777 on normal and leukemic hematopoiesis.

Liesveld JL, Lancet JE, Rosell KE, Menon A, Lu C, McNair C, Abboud CN, Rosenblatt JD. Liesveld JL, et al. Among authors: lancet je. Leukemia. 2003 Sep;17(9):1806-12. doi: 10.1038/sj.leu.2403063. Leukemia. 2003. PMID: 12970780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

229 results

Search Page